Barr Foresees Plan B OTC Launch In The Fall Pending “Approvable” Status
This article was originally published in The Tan Sheet
Executive Summary
Barr Labs expects its Plan B (levonorgestrel) emergency contraceptive to hit the market as an OTC by September at the earliest, assuming FDA says the product is approvable by the May 21 PDUFA deadline
You may also be interested in...
Plan B Pharmacy Access Movement Likely To Be Further Fueled By FDA Delay
State legislative efforts to make Barr's Plan B available directly from pharmacists will likely increase following FDA's latest deferral of a decision on the Rx-to-OTC switch of the drug
Plan B Pharmacy Access Movement Likely To Be Further Fueled By FDA Delay
State legislative efforts to make Barr's Plan B available directly from pharmacists will likely increase following FDA's latest deferral of a decision on the Rx-to-OTC switch of the drug
Plan B Pharmacy Access Movement Likely To Be Further Fueled By FDA Delay
State legislative efforts to make Barr's Plan B available directly from pharmacists will likely increase following FDA's latest deferral of a decision on the Rx-to-OTC switch of the drug